Yifeng Zheng
Overview
Explore the profile of Yifeng Zheng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
91
Citations
1313
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hsu P, Kamijyo Y, Koike E, Ichikawa S, Zheng Y, Ohno T, et al.
Front Nutr
. 2025 Feb;
12:1486572.
PMID: 39996007
Plant-derived exosome-like nanovesicles (ELNs) are critical mediators of cross-kingdom communication, modulating gene expression in animal cells despite their plant origin. In this study, we investigated the effects of glucoraphanin-enriched kale...
2.
Superior Active and Durable Air Electrode for Protonic Ceramic Cells by Metal-Oxide Bond Engineering
Yu X, Ge L, Mi Y, Wu B, Yu Z, Jin Z, et al.
Small
. 2025 Jan;
21(8):e2408607.
PMID: 39887623
Protonic ceramic cells (PCCs) have been identified as promising energy conversion devices, offering flexible fuel options and reduced operating consumption at intermediate temperatures. However, the application of traditional cobalt-based perovskite...
3.
Yu P, Zheng Y, Liu Z, Wei B, Zhang W, Lin Z, et al.
Entropy (Basel)
. 2025 Jan;
27(1.
PMID: 39851714
With the development of intelligent technology, data in practical applications show exponential growth in quantity and scale. Extracting the most distinguished attributes from complex datasets becomes a crucial problem. The...
4.
Zheng Y, Nutzl M, Schackel T, Chen J, Weidner N, Muller R, et al.
Bioact Mater
. 2025 Jan;
46:134-149.
PMID: 39760066
Biomaterial scaffold engineering presents great potential in promoting axonal regrowth after spinal cord injury (SCI), yet persistent challenges remain, including the surrounding host foreign body reaction and improper host-implant integration....
5.
Liang J, Ren Y, Zheng Y, Lin X, Song W, Zhu J, et al.
Mol Neurobiol
. 2024 Nov;
PMID: 39546118
Although several studies have identified a distinct gut microbiota in individuals with acute ischemic stroke (AIS), there is a limited amount of research that has simultaneously investigated alterations in the...
6.
Yuan W, Jiang Y, Sun M, Zhao Q, Qiao G, Zheng Y
Am J Transl Res
. 2024 Oct;
16(9):4770-4778.
PMID: 39398552
Objective: To investigate factors influencing social avoidance and distress (SAD) in patients following radical resection of lung cancer (RRLC) and analyze the mediating effects among these factors. Methods: Clinical data...
7.
Yang B, Li G, Wang S, Zheng Y, Zhang J, Pan B, et al.
Cell Death Dis
. 2024 Oct;
15(10):743.
PMID: 39394189
Autophagy-mediated chemoresistance is the core mechanism for therapeutic failure and poor prognosis in breast cancer. Breast cancer chemotherapy resistance is believed to be influenced by tumor-associated macrophages (TAMs), by which...
8.
Wang S, Xu S, Li J, Wang N, Zheng Y, Wang Z
Phytomedicine
. 2024 Sep;
135:156039.
PMID: 39303510
Background: Triple-negative breast cancer (TNBC) is challenged by the low chemotherapy response and poor prognosis. Emerging evidence suggests that cytotoxic chemotherapy may lead to the pro-metastatic tumor microenvironment (TME) by...
9.
Zheng B, Liang T, Mei J, Shi X, Liu X, Li S, et al.
ESC Heart Fail
. 2024 Aug;
11(6):4267-4276.
PMID: 39168476
Aims: Certain critical risk factors of heart failure with preserved ejection fraction (HFpEF) patients were significantly different from those of heart failure with reduced ejection fraction (HFrEF) patients, resulting in...
10.
Song Q, Zheng Y, Zhong G, Wang S, He C, Li M
Anticancer Agents Med Chem
. 2024 Aug;
24(18):1305-1326.
PMID: 39129164
Colorectal cancer is a common malignant tumor with high morbidity and mortality rates, imposing a huge burden on both patients and the healthcare system. Traditional treatments such as surgery, chemotherapy...